Clarification

Frank J. Loughery, Abbott Laboratories’ divisional vice president, wrote in a comment letter to the Financial Accounting Standards Board that there should be a reconsideration of the “exit price” concept in FASB’s proposal on fair-value measurement. A story in the Oct. 9 P&I Daily could have given the impression that Abbott had broader concerns about fair value.